Prior to joining the Alvogen leadership team, Chris was the Vice President of US and India Operations responsible for in-house and 3rd party operations, supply chain and the OTC business unit. Previously, he served as Managing Dir. of Solid Oral Dosage Operations for Actavis. During his 15 year tenure with Actavis, he led several cost improvement initiatives and start up operations which supported the aggressive growth of the company.
Chris Young holds an MBA from Rutgers University and a B.S. degree in biology from Gettysburg College.